Cargando…

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells

Glioblastoma (GBM) is the most lethal and aggressive adult brain tumor, requiring the development of efficacious therapeutics. Towards this goal, we screened five genetically distinct patient-derived brain-tumor initiating cell lines (BTIC) with a unique collection of small molecule epigenetic modul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grinshtein, Natalie, Rioseco, Constanza C., Marcellus, Richard, Uehling, David, Aman, Ahmed, Lun, Xueqing, Muto, Osamu, Podmore, Lauren, Lever, Jake, Shen, Yaoqing, Blough, Michael D., Cairncross, Greg J., Robbins, Stephen M., Jones, Steven J., Marra, Marco A., Al-Awar, Rima, Senger, Donna L., Kaplan, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312317/ https://www.ncbi.nlm.nih.gov/pubmed/27449082 http://dx.doi.org/10.18632/oncotarget.10661

Ejemplares similares

Small molecules reveal an alternative mechanism of Bax activation
por: Brahmbhatt, Hetal, et al.
Publicado: (2016)

G protein–coupled receptor kinase 6 (GRK6) regulates insulin processing and secretion via effects on proinsulin conversion to insulin
por: Varney, Matthew J., et al.
Publicado: (2022)

Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay
por: Hammoud, Lamis, et al.
Publicado: (2016)

Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
por: De Boeck, Astrid, et al.
Publicado: (2020)

ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
por: Yuan, Alice L., et al.
Publicado: (2018)

EXPLORING THE ROLE OF GAT1 AND GABA IN TEMOZOLOMIDE TREATED GLIOMA
por: Poole, Alisha, et al.
Publicado: (2023)

Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers
por: Coulter, Jonathan B., et al.
Publicado: (2023)

G protein–receptor kinases 5/6 are the key regulators of G protein–coupled receptor 35–arrestin interactions
por: Ganguly, Amlan, et al.
Publicado: (2023)

Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC
por: Schade, Amy E., et al.
Publicado: (2023)

PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
por: Babichev, Yael, et al.
Publicado: (2016)

MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9
por: Jin, Qifang, et al.
Publicado: (2018)

PDGF gene expression and p53 alterations contribute to the biology of diffuse astrocytic gliomas
por: Kumar, Mehul, et al.
Publicado: (2023)

HDAC1,2 inhibition impairs EZH2- and BBAP- mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma
por: Johnson, Danielle P., et al.
Publicado: (2014)

SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells
por: Koumangoye, Rainelli B, et al.
Publicado: (2015)

Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers
por: Cohen, Adam L, et al.
Publicado: (2013)

Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K
por: Liu, Jeff C, et al.
Publicado: (2014)

The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
por: Edilova, Maria I., et al.
Publicado: (2021)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2
por: Lau-Corona, Dana, et al.
Publicado: (2020)

Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors
por: Ahmad, Shiekh Tanveer, et al.
Publicado: (2019)

Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma
por: Han, Ting, et al.
Publicado: (2020)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
por: Dhar, Swati, et al.
Publicado: (2022)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Hdac1 and Hdac2 regulate the quiescent state and survival of hair-follicle mesenchymal niche
por: Sibony-Benyamini, Hadas, et al.
Publicado: (2023)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Tazemetostat: EZH2 Inhibitor
por: Straining, Rachael, et al.
Publicado: (2022)

Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor
por: Wang, LiMei, et al.
Publicado: (2008)

EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Lui, Julian C., et al.
Publicado: (2016)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance
por: Xie, Yunxia, et al.
Publicado: (2022)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

Conference on Penetration of Charged Particles in Matter
por: Uehling, Edwin A
Publicado: (1960)

NUCLEAR DEFECTIVE IL-33 DRIVES AN ANTI-TUMORIGENIC MICROENVIRONMENT IN GLIOBLASTOMA
por: Menon, Shyam V, et al.
Publicado: (2023)

Ezh1 arises from Ezh2 gene duplication but its function is not required for zebrafish development
por: Völkel, Pamela, et al.
Publicado: (2019)

Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
por: Muto, Tomoya, et al.
Publicado: (2013)

The histone methyltransferase Ezh2 restrains macrophage inflammatory responses
por: Kitchen, Gareth B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qpsj3jggms6pnh23jjcehs4kvk